| Gastric cancer EC Smyth, M Nilsson, HI Grabsch, NCT van Grieken, F Lordick The Lancet 396 (10251), 635-648, 2020 | 2633 | 2020 |
| Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up EC Smyth, M Verheij, W Allum, D Cunningham, A Cervantes, D Arnold Annals of oncology 27, v38-v49, 2016 | 1650 | 2016 |
| Patient-derived organoids model treatment response of metastatic gastrointestinal cancers G Vlachogiannis, S Hedayat, A Vatsiou, Y Jamin, J Fernández-Mateos, ... Science 359 (6378), 920-926, 2018 | 1478 | 2018 |
| Oesophageal cancer J Lagergren, E Smyth, D Cunningham, P Lagergren The Lancet 390 (10110), 2383-2396, 2017 | 1013 | 2017 |
| Oesophageal cancer EC Smyth, J Lagergren, RC Fitzgerald, F Lordick, MA Shah, P Lagergren, ... Nature reviews Disease primers 3 (1), 1-21, 2017 | 849 | 2017 |
| Mismatch repair deficiency, microsatellite instability, and survival: an exploratory analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) trial EC Smyth, A Wotherspoon, C Peckitt, D Gonzalez, S Hulkki-Wilson, ... JAMA oncology 3 (9), 1197-1203, 2017 | 490 | 2017 |
| Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆ F Lordick, F Carneiro, S Cascinu, T Fleitas, K Haustermans, G Piessen, ... Annals of Oncology 33 (10), 1005-1020, 2022 | 434 | 2022 |
| Individual patient data meta-analysis of the value of microsatellite instability as a biomarker in gastric cancer F Pietrantonio, R Miceli, A Raimondi, YW Kim, WK Kang, RE Langley, ... Journal of Clinical Oncology 37 (35), 3392-3400, 2019 | 357 | 2019 |
| Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus G Curigliano, S Banerjee, A Cervantes, MC Garassino, P Garrido, ... Annals of Oncology 31 (10), 1320-1335, 2020 | 304 | 2020 |
| Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a … D Cunningham, SP Stenning, EC Smyth, AF Okines, WH Allum, S Rowley, ... The Lancet Oncology 18 (3), 357-370, 2017 | 288 | 2017 |
| Effect of pathologic tumor response and nodal status on survival in the medical research council adjuvant gastric infusional chemotherapy trial EC Smyth, M Fassan, D Cunningham, WH Allum, AFC Okines, A Lampis, ... Journal of Clinical Oncology 34 (23), 2721, 2016 | 265 | 2016 |
| Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction AR Davies, JA Gossage, J Zylstra, F Mattsson, J Lagergren, N Maisey, ... Journal of Clinical Oncology 32 (27), 2983-2990, 2014 | 263 | 2014 |
| High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial A Pearson, E Smyth, IS Babina, MT Herrera-Abreu, N Tarazona, C Peckitt, ... Cancer discovery 6 (8), 838-851, 2016 | 256 | 2016 |
| Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up A Oaknin, TJ Bosse, CL Creutzberg, G Giornelli, P Harter, F Joly, ... Annals of oncology 33 (9), 860-877, 2022 | 202 | 2022 |
| Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆ R Obermannová, M Alsina, A Cervantes, T Leong, F Lordick, M Nilsson, ... Annals of Oncology 33 (10), 992-1004, 2022 | 195 | 2022 |
| Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS K Muro, E Van Cutsem, Y Narita, G Pentheroudakis, E Baba, J Li, MH Ryu, ... Annals of Oncology 30 (1), 19-33, 2019 | 195 | 2019 |
| A prospective evaluation of the utility of 2‐deoxy‐2‐[18F] fluoro‐D‐glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer E Smyth, H Schöder, VE Strong, M Capanu, DP Kelsen, DG Coit, ... Cancer 118 (22), 5481-5488, 2012 | 174 | 2012 |
| Fibroblast growth factor receptors, developmental corruption and malignant disease FC Kelleher, H O’Sullivan, E Smyth, R McDermott, A Viterbo Carcinogenesis 34 (10), 2198-2205, 2013 | 155 | 2013 |
| Colorectal liver metastases: Current management and future perspectives J Martin, A Petrillo, EC Smyth, N Shaida, S Khwaja, HK Cheow, ... World journal of clinical oncology 11 (10), 761, 2020 | 133 | 2020 |
| Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors EC Smyth, F Sclafani, D Cunningham OncoTargets and therapy, 1001-1014, 2014 | 133 | 2014 |
